Hem › Diffust storcelligt B-cellslymfom › Washington › Seattle
Kliniska studier för Diffust storcelligt B-cellslymfom i Seattle, WA
12 studier för Diffust storcelligt B-cellslymfom söker deltagare vid platser i och runt Seattle (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RekryterarFas 2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekryterarFas 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekryterarFas 1
- University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance), Seattle
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekryterarFas 1
- Swedish Cancer Institute (SCI), Seattle
Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
RekryterarFas 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RekryterarFas 1/2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
DALY II USA/ MB-CART2019.1 for DLBCL
RekryterarFas 2
- Fred Hutchinson Cancer Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
RekryterarFas 2Friska volontärer välkomna
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
RekryterarFas 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
RekryterarFas 2
- Swedish Medical Center-First Hill, Seattle
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekryterarFas 1
- Swedish Cancer Institute, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
RekryterarFas 1
- Fred Hutchinson Cancer Center, Seattle
Diffust storcelligt B-cellslymfom-studier i andra städer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Los Angeles, CA17 studier
- Houston, TX17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Portland, OR15 studier
- Nashville, TN15 studier
- Philadelphia, PA15 studier
- Durham, NC14 studier
- Dallas, TX13 studier
Andra studier i Seattle
- Icke-småcellig lungcancer53 studier
- Cancer (alla typer)49 studier
- Prostatacancer42 studier
- Akut myeloid leukemi40 studier
- Bröstcancer39 studier
- Metastaserande cancer39 studier
- Kolorektal cancer34 studier
- Lungcancer33 studier
- Äggstockscancer30 studier
- Multipelt myelom22 studier
- Myelodysplastiska syndrom21 studier
- Akut lymfoblastisk leukemi21 studier
Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.